You are here: Industry Insights > Truxima

News List

Teva Canada Announces the Approval of TRUXIMA, the first biosimilar to RITUXAN in Canada for the Treatment of Non-Hodgkin's Lymphoma firstwordpharma
April 11, 2019
Teva Canada Innovation, G.P.-.S.E.N.C. announces that Health Canada has granted a notice ……
FDA Approves First Biosimilar for Non-Hodgkin’s Lymphoma americanpharmaceuticalreview
November 29, 2018
The U.S. Food and Drug Administration (FDA) approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive.....
FDA Approves Truxima drugs
November 29, 2018
FDA Approves Truxima (rituximab-abbs), a Biosimilar to Rituxan for Non-Hodgkin’s Lymphoma
Celltrion's Rituxan biosimilar gets unanimous backing from FDA committee pharmafile
November 20, 2018
FDA approval looks to be in reach for Celltrion, as an advisory committee for the US regulator voted unanimously to recommend Truxima, its biosimilar version of Roche’s Rituxan (rituximab), in the treatment of cancer.